Back to results
US 5,962,302 AGranted
Human N-acetylneuraminate lyase
AssigneeIncyte Pharmaceuticals, Inc.
InventorsJennifer L. Hillman, Purvi Shah, Neil C. Corley
Life of this patent
Estimating the term…
Abstract
The invention provides a human N-acetylneuraminate lyase (HNANL) and polynucleotides which identify and encode HNANL. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HNANL.
Claims10
An isolated and purified polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 1 or a fragment of SEQ ID NO:1 having N-acetylneuraminate lyase activity.
An isolated and purified polynucleotide comprising the polynucleotide sequence of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.